Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

NCT: NCT07114718 · RECRUITING

NCT IDNCT07114718
StatusRECRUITING
Start Date2026-01-16
Completion2028-04

Brief Summary

Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart.

Frequently Asked Questions

What is Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study?

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study is a clinical trial registered under NCT07114718. Current status: RECRUITING.

What is the status of NCT07114718?

The current status of NCT07114718 (Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study) is: RECRUITING.

When did Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study start?

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study started on 2026-01-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑